lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
Nature Medicine2017Vol. 23(11), pp. 1331–1341
Citations Over TimeTop 1% of 2017 papers
Yuanyuan Lu, Xiaodi Zhao, Qi Liu, Cunxi Li, Ramona Graves‐Deal, Zheng Cao, Bhuminder Singh, Jeffrey L. Franklin, Jing Wang, Huaying Hu, Tianying Wei, Mingli Yang, Timothy J. Yeatman, Ethan Lee, Kenyi Saito‐Diaz, Scott A. Hinger, James G. Patton, Christine H. Chung, Stephan Emmrich, Jan‐Henning Klusmann, Daiming Fan, Robert J. Coffey
Related Papers
- → Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer(2006)110 cited
- → Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII(2007)35 cited
- → Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines(2017)18 cited
- Cetuximab in Patients with Non-Small Cell Lung Cancer and EGFR Exon 20 Insertion Alterations.(2022)
- Research of microRNA and epigenetics in Alzheimer's disease(2011)